Closure of the deal is to take place at the end of March. Gerresheimer thereby consistently continues its expansion in the target market of pharma/life-science.
In this highly specialised market, Gerresheimer ranks among the leading international suppliers of both glass and plastic products. Comar uses tubular glass to produce high-quality pharmaceutical vials and system components for pharmaceutics, diagnostics and analytical systems.
Gerresheimer is one of the leading manufacturers of pharma glass in the US and over a number of years has pushed ahead to achieve further business expansion through targeted acquisitions in this attractive market.
Gerresheimer now has eight production plants in North America to supply the dynamic pharma/life-science business. "With highly-developed production technologies and an outstanding product range, the Glass Division of Comar ideally complements the Gerresheimer product portfolio," says Dr. Axel Herberg, President and CEO of the Gerresheimer Group. The Comar Glass Division has been firmly established in the American market for almost sixty years. With around 200 employees, up-to-date technologies and a top-quality product range, the company is highly regarded by its customers. The product range of the pharma-glass and diagnostics business taken over by Gerresheimer comprises a wide variety of pharmaceutical vials and sophisticated glass components for diagnostic and analytical systems. Comar sales in the pharma glass sector totalled around US$24m in 2006.
Read the entire news on the source link below.